Clintrax Global Partners With Acorn Applications To Extend Clinical Trial Contracting Solution
Acorn Applications, a developer of cloud-based analytic clinical research solutions, announced today that Clintrax Global, a clinical trial contract negotiation company, has selected TrialCTA as its new global contract management software solution.
TrialCTA, Acorn Applications' lead product, is a cloud-based Software-as-a-Service (SaaS) application that helps Clinical Research Organizations (CRO's), medical device, and pharmaceutical companies manage and track the complex, global clinical trial contracts associated with clinical research studies. The application combines an intuitive workflow with a flexible rules engine to manage, track and accelerate clinical research study site contracts. In addition, TrialCTA is built upon Acorn Applications' advanced technology that provides built-in integration capability with any external system including Document Management, EDC, CTMS or IVR, allowing seamless incorporation of contract negotiation data into the overall clinical trial site initiation process.
"We chose TrialCTA because it is the only system on the market specifically designed for the Clinical Trial Agreement (CTA) lifecycle, which greatly enhances our global service offering," said Brandon Evans, CEO of Clintrax Global, Inc. "This system enables us to provide real-time, accurate reporting and transparency to our clients. TrialCTA is fully customizable, giving us the ability to cater to the different tracking and reporting needs for each client. More importantly, its flexible notification system ensures that no agreement is lost or neglected. Both of our companies are very excited to embark on this mutually beneficial relationship."
Gordon Jones, CEO of Acorn Applications, stated, "Clintrax Global's business is clinical study contracting, so we're extremely proud to have been selected to assist them. Study sponsors are demanding real-time transparency and faster study startup, so we designed TrialCTA from the ground up to specifically meet the tracking needs of Clinical Trial Agreements."